Home » Topics » Disease categories and therapies » Urology

Urology
RSS

European approval recommended for Emselex

Aug. 3, 2004

Further positive phase I/II data for NX-1207 in BPH

Aug. 2, 2004

Chinese researchers identify novel agents for renal disorders

July 30, 2004

Novel dopamine D3 agonists and their use in sexual disorders

July 29, 2004

INNOVATION study of Micardis completes enrollment

July 28, 2004

Abbott and Deltanoid to develop fourth generation active D therapies

July 27, 2004

FDA extends Fosrenol review

July 22, 2004

Significant association found between coronary artery risk factors and erectile dysfunction

July 20, 2004

Phase II protocol for NX-1207 accepted by FDA

July 19, 2004

Zonagen reports Androxal phase I/II study results

July 19, 2004

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 29, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 26, 2026
TROP2 ADCs progress into first-line for lung, breast cancers
BioWorld
Multiple updates on TROP2-directed antibody-drug conjugates (ADCs) for lung and breast cancers highlight both progress made and opportunities for improvement for...
Researchers identify innate immune barrier against melanoma
BioWorld
Australian researchers have identified a previously overlooked population of immune cells in the skin that physically restrain melanoma growth by engulfing live...
Cavalon Therapeutics and Northwestern patent new Cav1.3 blockers
BioWorld Science
Cavalon Therapeutics Inc. and Northwestern University have disclosed new voltage-gated calcium channel Cav1.3 blockers potentially useful for the treatment of...